Keywords: cellcept, approved, heart, transplants, eu, roche, immunosuppressant

CellCept Approved For Heart Transplants In EU

Article | 21 August 1998

Roche's immunosuppressant drug CellCept (mycophenolate mofetil) hasbeen approved in the European Union for an additional indication, the prevention of organ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

CellCept

Mycophenolate Mofetil

Go to drug listing